Collagen accumulation over time in the murine lung after exposure to crocidolite asbestos or libby amphibole

Environmental Toxicology

Volumn 25, Issue 1, 2010, Pages 68-76

  Smartt, Aubrey M ^a   Brezinski, Mary ^a   Trapkus, Melanie ^a   Gardner, Donald ^b   Putnam, Elizabeth A ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Asbestos; Collagen; Extracellular matrix; Fibrosis

Indexed keywords

AMPHIBOLE FIBERS; ASBESTOS-RELATED DISEASE; C57BL/6 MICE; COLLAGEN ACCUMULATION; COLLAGEN DEPOSITION; COLLAGEN PROTEINS; CROCIDOLITE ASBESTOS; EXTRACELLULAR MATRICES; EXTRACELLULAR MATRIX; MODEL SYSTEM; MOUSE MODELS; MRNA EXPRESSION;

ASBESTOS; BIOLOGICAL ORGANS; CLAY MINERALS; ENZYME ACTIVITY; GENE EXPRESSION; HEALTH RISKS; IGNEOUS ROCKS; MINING; RNA;

COLLAGEN;

AMPHIBOLE; COLLAGEN; CROCIDOLITE; PROTEIN; RNA;

AMPHIBOLE; ASBESTOS; BIOACCUMULATION; COLLAGEN; GENE EXPRESSION; HEALTH RISK; POLLUTION EFFECT; POLLUTION EXPOSURE; RNA; RODENT; VERMICULITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; C57BL 6 MOUSE; COMPARATIVE STUDY; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; EXPERIMENTAL MODEL; EXTRACELLULAR MATRIX; FEMALE; FIBROSIS; LUNG; MALE; MORPHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ASBESTOS, AMPHIBOLE; COLLAGEN; DRUG ADMINISTRATION SCHEDULE; LUNG; MICE; MICE, INBRED C57BL; PULMONARY FIBROSIS;

ASBESTOS; CLAY; COLLAGEN; ENZYMATIC ACTIVITY; HEALTH; MINING; NUCLEIC ACIDS; RISK ASSESSMENT;

MURINAE; MUS;

EID: 76749118495     PISSN: 15204081     EISSN: 15227278     Source Type: Journal    
DOI: 10.1002/tox.20472     Document Type: Article

References (35)

1. Adamson IY, Bowden DH. 1987. Response of mouse lung to crocidolite asbestos. Part II: Pulmonary fibrosis after long fibres. J Pathol 152:109-117.
2. Agency for Toxic Substances and Disease Registry (ATSDR). 2000. Health consultation: Mortality from asbestosis in Libby, Montana, 1979-1998.
3. Amandus HE, Wheeler R. 1987. The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite. Part II: Mortality. Am J Ind Med 11:15-26.
4. Amandus HE, Wheeler R, Jankovic J, Tucker J. 1987. The morbidity and mortality of vermiculite miners and millers exposed to tremolite-actinolite. Part I: Exposure estimates. Am J Ind Med 11:1-14.
5. American Thoracic Society. 1986. Diagnosis of nonmalignant diseases related to asbestos. Am Rev Respir Dis 134:363-368.
6. Baldys A, Pande P, Mosleh T, Park SH, Aust AE. 2007. Apoptosis induced by crocidolite asbestos in human lung epithelial cells involves inactivation of Akt and MAPK pathways. Apoptosis 12:433-447.
7. Bernstein DM, Chevalier J, Smith P. 2005. Comparison of Calidria chrysotile asbestos to pure tremolite: Final results of the inhalation biopersistence and histopathology examination following short-term exposure. Inhalation Toxicol 17:427-449.
8. Blake DJ, Bolin CM, Cox DP, Cardozo-Pelaez F, Pfau JC. 2007. Internalization of Libby amphibole asbestos and induction of oxidative stress in murine macrophages. Toxicol Sci 99:277-288.
9. Brody AR, Hill LH, Adkins B Jr, O'Connor RW. 1981. Chrysotile asbestos inhalation in rats: Deposition pattern and reaction of alveolar epithelium and pulmonary macrophages. Am Rev Respir Dis 1283:670-679.
10. Brody AR, Roe MW. 1983. Deposition pattern of inorganic particles at the alveolar level in the lungs of rats and mice. Am Rev Respir Dis 128:724-729.
11. Brown RFR, Drawbaugh RB, Marrs TC. 1988. An investigation of possible models for the production of progressive pulmonary fibrosis in the rat. The effects of repeated intratracheal instillation of bleomycin. Toxicology 51:101-110.
12. Chang LY, Overby LH, Brody AR, Crapo JD. 1988. Progressive lung cell reactions and extracellular matrix production after a brief exposure to asbestos. Am J Pathol 131:156-170.
13. Chapman HA. 2004. Disorders of lung matrix remodeling. J Clin Invest 113:148-157.
14. Collan Y, Kosma VM, Anttonen H, Kulju T. 1986. Toxicity of richterite in hemolysis test and macrophage cultures. Arch Toxicol Suppl 9:292-295.
15. Craighead JE, Abraham JL, Churg A, Green FHY, Kleinerman J, Pratt PC, Seemayer TA, Vallyathan V, Weill H. 1982. The pathology of asbestos-associated diseases of the lungs and pleural cavities: Diagnostic criteria and proposed grading schema. Report of the Pneumoconiosis Committee of the College of American Pathologists and the National Institute for Occupational Safety and Health. Arch Pathol Lab Med 106:544-596.
16. Cutroneo KR. 2003. How is type I procollagen synthesis regulated at the gene level during tissue fibrosis. J Cell Biochem 90:1-5.
17. Ghosh AK. 2002. Factors involved in the regulation of type I collagen gene expression: Implication in fibrosis. Exp Biol Med 227:301-314.
18. Gunter ME, Dyar DM, Twamley B, Foit FF, Cornelius S. 2003. Composition, Fe+3/ΣFe and crystal structure of non-asbestiform and asbestiform amphiboles from Libby, Montana, USA. Am Mineral 88:1944-1952.
19. Hamilton RF Jr, Holian A, Morandi MT. 2004. A comparison of asbestos and urban particulate matter in the in vitro modification of human alveolar macrophage antigen-presenting cell function. Exp Lung Res 30:147-162.
20. Hoyt DG, Lazo JS. 1988. Alterations in pulmonary mRNA encoding procollagens, fibronectin and transforming growth factor-beta precede bleomycin-induced pulmonary fibrosis in mice. J Pharmacol Exp Ther 246:765-771.
21. Kamp DW, Weitzman SA. 1999. The molecular basis of asbestos induced lung injury. Thorax 54:638-652.
22. Lazenby AJ, Crouch EC, McDonald JA, Kuhn C. 1990. Remodeling of the lung in bleomycin-induced pulmonary fibrosis in the rat. An immunohistochemical study of laminin, type IV collagen, and fibronectin. Am Rev Respir Dis 142:206-214.
23. Manning CB, Vallyathan V, Mossman BT. 2002. Diseases caused by asbestos: Mechanisms of injury and disease development. Int Immunopharmacol 2:191-200.
24. McDonald JC, Harris J, Armstrong B. 1986. Cohort study of mortality of vermiculite miners exposed to tremolite. Br J Ind Med 43:436-444.
25. Meeker GP, Bern AM, Brownfield IK, Lowers HA, Sutley SJ, Hoefen TM, Vance JS. 2003. The composition and morphology of ampiboles from the rainy creek complex, near Libby, Montana. Am Mineral 88:1955-1969.
26. Moatamed F, Lockey JE, Parry WT. 1986. Fiber contamination of vermiculites: A potential occupational and environmental health hazard. Env Res 41:207-218.
27. Peipins LA, Lewin M, Campolucci S, Lybarger JA, Miller A, Middleton D, Weis C, Spence M, Black B, Kapil V. 2003. Radiographic abnormalities and exposure to asbestos-contaminated vermiculite in the community of Libby, Montana, USA. Environ Health Perspect 111:1753-1759.
28. Putnam EA, Smartt A, Groves A, Schwanke C, Brezinski M, Pershouse MA. 2008. Gene expression changes after exposure to six-mix in a mouse model. J Immunotoxicol 5:139-144.
29. Sullivan PA. 2007. Vermiculite, respiratory disease, and asbestos exposure in Libby, Montana: Update of a cohort mortality study. Environ Health Perspect 115:579-585.
30. Swiderski RE, Dencoff JE, Floerchinger CS, Shapiro SD, Hunninghake GW. 1998. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycininduced pulmonary fibrosis. Am J Pathol 152:821-828.
31. United States Environmental Protection Agency. 2008. Asbestos contamination in Vermiculite. Vermiculite and its uses. Available at: http://www.epa.gov/asbestos/pubs/verm.html. Accessed 22 April 2008.
32. Wake B. 1962. A report on an industrial hygiene study of the zonolite company, Libby, Montana. April 19, 1962. Helena, MT: Montana State Board of Health. Division of Disease Control.
33. Woessner JF. 1961. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. Arch Biochem Biophys 93:440-447.
34. Wright RS, Abraham JL, Harber P, Burnett BR, Morris P, West P. 2002. Fatal asbestosis 50 years after brief high intensity exposure in a vermiculite expansion plant. Am J Respir Crit Care Med 165:1145-1149.
35. Wylie AG, Verkouteren JR. 2000. Amphibole asbestos from Libby, Montana, aspects of nomenclature. Am Mineral 85: 1540-1542.